ACS expands lung cancer screening eligibility to ages 50-80 with 20+ pack-years

Previous guideline was 55-74 with 30+ pack years

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Lung Cancer Awareness Month kicked off this week, and this is a monumental one for us at the American Cancer Society.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Robert A. Smith, PhD
Senior vice president, Early Cancer Detection Science, American Cancer Society
William L. Dahut, MD
Chief scientific officer, American Cancer Society
Table of Contents

YOU MAY BE INTERESTED IN

Tagrisso (osimertinib) demonstrated a sustained, clinically meaningful overall survival benefit at eight years compared to placebo in the adjuvant treatment of patients with early-stage (1B, 2, and 3A) epidermal growth factor receptor-mutated non-small cell lung cancer after complete tumor resection with curative intent, according to the updated exploratory results from the ADAURA phase III trial. 
Harold P. Freeman, a surgeon who started his career in Harlem, where, in addition to performing surgeries, he pioneered the system of patient navigation, and who studied health disparities and served as president of the American Cancer Society and chair of the President’s Cancer Panel, died on Aug. 11. He was 93.
Robert A. Smith, PhD
Senior vice president, Early Cancer Detection Science, American Cancer Society
William L. Dahut, MD
Chief scientific officer, American Cancer Society

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login